Sarepta Therapeutics
The Director, Patient Advocacy serves as a strategic leader within the Patient Affairs organization, responsible for shaping and advancing advocacy strategies that deepen Sarepta’s partnerships with patient communities and integrate patient perspectives across the company’s business and development priorities. This role drives high-impact collaborations with patient advocacy organizations and global patient community engagement while ensuring patient and caregiver perspectives are incorporated into cross-functional planning and decision-making. The position acts as both an internal strategist and external relationship leader to help Sarepta deliver on its mission through authentic community partnership and patient-centered leadership.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sarepta Therapeutics.
Sarepta Therapeutics CEO Doug Ingram will retire after a tumultuous decade
2 weeks ago
Director, Patient Advocacy, Inherited Metabolic Disorders (IMD)
ITF Therapeutics
Director, Patient Advocacy - Rare Oncology Disease
ICON
Director, Patient Advocacy
Alfasigma
Senior Manager, Patient Advocacy
PharmaEssentia
Director, Global Oncology Patient Advocacy
Immatics
Director, Patient Innovation & Engagement - Japan, China and Asia Pacific (JCAP)
MSD